XML 34 R25.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SHAREHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2024
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of stock options granted
   
Six months ended
June 30, 2024
 
   
Number
of options
   
Weighted
average
exercise
price
   
Weighted average remaining contractual term
(in years)
   
Aggregate
intrinsic
value
 
                     
$ thousands
 
                         
Outstanding at beginning of year
   
5,625,482
     
2.71
     
3.66
     
300
 
Granted
   
451,823
     
2.88
                 
Exercised
   
(234,127
)
   
2.31
                 
Forfeited or expired
   
(626,739
)
   
3.18
                 
                                 
Outstanding at end of the period
   
5,216,439
     
2.68
     
3.67
     
994
 
                                 
Options exercisable at end of the period
   
2,986,522
     
2.82
     
3.08
     
383
 
                                 
Vested and expected to vest
   
4,846,189
     
2.71
     
3.58
     
876
 
Schedule of RSUs granted
   
Six months ended
June 30, 2024
 
   
Number of
RSUs
   
Weighted average fair value
 
             
Unvested at beginning of year
   
2,622,195
     
2.42
 
Granted
   
439,677
     
2.63
 
Vested
   
(218,031
)
   
2.27
 
Forfeited
   
(71,740
)
   
2.31
 
                 
Unvested at end of period
   
2,772,101
     
2.47
 
Schedule of equity-based compensation expense
   
Six months ended
June 30,
 
   
2024
   
2023
 
   
$ thousands
 
             
Cost of revenues
   
265
     
226
 
Research and development
   
336
     
477
 
Sales and Marketing
   
683
     
738
 
General and administrative
   
1,186
     
536
 
                 
Total share-based compensation expense
   
2,470
     
1,977